← EU Feed

Novo Nordisk's adjusted operating profit reached DKK 32,858 million in Q1 2026

AI Briefing

  • Novo Nordisk raises 2026 guidance after strong Q1 sales
  • Wegovy leads to adjusted operating profit of DKK 32,858 million
  • International Operations drive growth
Advertisement
Read Original Article